Company intelligence / Profile preview
Universal Corporation Limited
Kikuyu, Kiambu, Kenyaucl.co.ke ↗
- Ownership
- Private
- Employees
- ~400
- Development stage
- Other
01
Overview
Universal Corporation Limited is a leading Kenyan pharmaceutical manufacturer with WHO prequalification for several products. It was the first African company to receive WHO prequalification to produce sulfadoxine-pyrimethamine + amodiaquine (SPAQ) for malaria prevention. The company manufactures over 100 formulations of human medicines and supplies more than 20 African countries. Its facility is one of only two WHO PQ plants in Sub-Saharan Africa and has maintained this status for over a decade.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Finfund (investor)UNICEF/WHO procurement partnerships via prequalified products
Beyond the preview
Go deeper on Universal Corporation Limited.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Universal Corporation Limited.